|Articles|August 1, 2001
- Pharmaceutical Executive-08-01-2001
- Volume 0
- Issue 0
Mergers: Big Pharma Shrinks Some
Author(s)Kevin Gopal
London-GlaxoSmithKline is proposing to cut more than 2,000 jobs from its worldwide workforce of 100,000 as it seeks to generate the promised savings from its merger.
Advertisement
Articles in this issue
over 24 years ago
Decision Making at Digital Speedover 24 years ago
Generics: Streamline and Stimulateover 24 years ago
Grace Under Fireover 24 years ago
Get Ready to Merge or Divergeover 24 years ago
Pharma's Quantum Shuffleover 24 years ago
Science-Driven MarketingNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Report: Richard Pazdur Out as Director of CDER
2
Pharmaceutical Commercialization: A 2026 Outlook Personalization and Precision Will Define a New Year in Pharma
3
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
4
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
5
